The effects of cinnarizine versus sodium valproate in migraine prophylaxis

References

• Goadsby PJ, Lipton RB, Ferrari MD. Migraine-current understanding and treatment. N Engl J Med 2002;346:257–70.
   PubMed Web of Science ®Google Scholar
• Hamalainen ML. Migraine in children and adolescents: a guide to drug treatment. CNS Drugs 2006;20:813–20.
   PubMedGoogle Scholar
• Lipton RB, Bigal ME, Diamond M, Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007;68:343–9.
   PubMed Web of Science ®Google Scholar
• Buchanan TM, Ramadan NM. Prophylactic pharmacotherapy for migraine headaches. Semin Neurol 2006;26:188–98.
   PubMedGoogle Scholar
• Diener HC, Limmroth V. Migraine therapy. Internist (Berl) 2005;46:1087–95.
   PubMedGoogle Scholar
• Mathew NT, Saper JR, Silberstein SD, Migraine prophylaxis with divalproex. Arch Neurol 1995;52:281–6.
   PubMed Web of Science ®Google Scholar
• Klapper J. Divalproex sodium in migraine prophylaxis: a dose controlled study. Cephalalgia 1997;17:103–8.
   PubMed Web of Science ®Google Scholar
• Mathew NT, Rapoport A, Saper J. Efficacy of gabapentin in migraine prophylaxis. Headache 2001;41:119–28.
   PubMed Web of Science ®Google Scholar
• Freitag FG, Collins SD, Carlson HA. A randomized trial of divalproex sodium extended release tablets in migraine prophylaxis. Neurology 2002;58:1652–9.
   PubMed Web of Science ®Google Scholar
• Togha M, Ashrafian H, Tajik P. Open-label trial of cinnarizine in migraine prophylaxis. Headache 2006;46:498–502.
   PubMed Web of Science ®Google Scholar
• Rossi P, Fiermonte G, Pierelli F. Cinnarizine in migraine prophylaxis: efficacy, tolerability and predictive factors for therapeutic responsiveness. An open-label pilot trial. Funct Neurol 2003;18:155–9.
   PubMed Web of Science ®Google Scholar
• The International Headache Society Committee on Clinical Trials on Migraine. Guidelines for controlled trials of drugs in migraine, 1st edn. Cephalalgia 1991;11:1–12.
   Google Scholar
• Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias, and facial pain. Cephalalgia 1988;8(Suppl 7):1–96.
   Google Scholar
• Amelin AV, Skoromets AA, Gonchar MA, Comparative efficacy of betaserc and cinnarizine in vertigo in patients with migraine. Zh Neurol Psikhiatr Im S S Korsakova 2003;103: 43–8.
   PubMedGoogle Scholar
• Togha M, Rahmat Jirde M, Nilavari K, Cinnarizine in refractory migraine prophylaxis: efficacy and tolerability. A comparison with sodium valproate. J Headache Pain 2008;9:77–82.
   PubMed Web of Science ®Google Scholar
• Punay NC, Couch JR. Antidepressants in the treatment of migraine headache. Curr Pain Headache Rep 2003;7:51–4.
   PubMedGoogle Scholar
• Storey JR, Calder CS, Hart DE, Potter DL. Topiramate in migraine prevention: a double-blind, placebo-controlled study. Headache 2001;41:968–75.
   PubMed Web of Science ®Google Scholar
• Rapoport A, Mauskop A, Diener HC, Long-term migraine prevention with topiramate: open-label extension of pivotal trials. Headache 2006;46:1151–60.
   PubMed Web of Science ®Google Scholar
• Dariush A, Shabnam R, Mansour R. A Comparative Study of the Effects of Low-Dose Topiramate Versus Sodium Valproate in Migraine Prophylaxis. International journal of Neuroscience 2012 Feb;122(2):60–68.
   PubMedGoogle Scholar
• Erdemoglu AK, Ozbakir S. Valproic acid in prophylaxis of refractory migraine. Acta Neurol Scand 2000;102:354–358.
   PubMedGoogle Scholar
• The International Classification of Headache Disorders. 2nd ed. Headache Classification Subcommittee of the International Headache Society. Cephalagia (Oxford, England, UK: Blackwell Publishing) 2004;24(1):1–160.
   Google Scholar
• Bassi P, Brunati L, Rapuzzi B, Low dose flunarizine in the prophylaxis of migraine. Headache 1992;32:390–2.
   PubMed Web of Science ®Google Scholar
• Macedo A, Banos JE, Farre M. Placebo response in the prophylaxis of migraine: a meta-analysis. Eur J Pain 2008;12:68–75.
   PubMed Web of Science ®Google Scholar
• Freitag FG, Collins SD, Carlson BA, Goldstein BA. A randomized trial of divalproex sodium extended –release tablets in migraine prophylaxis. Neurology 2002;58:1652–9.
   PubMed Web of Science ®Google Scholar
• Mathew NT, Saper JR, Silberstain SD, Migraine prophylaxis with divalproex. Arch Neurol 1995;52:281–6.
   PubMed Web of Science ®Google Scholar
• Klapper J. Divalproex sodium in migraine prophylaxis: a dose-controlled study. Cephalalgia 1997;17:103–8.
   PubMed Web of Science ®Google Scholar
• Mathew NT, Rapoport A, Saper J, Efficacy of gabapentin in migraine prophylaxis. Headache 2001;41:119–28.
   PubMed Web of Science ®Google Scholar
• Hering R, Kuritzky A. Sodium valproate in the prophylactic treatment of migraine: a double-blind study versus placebo. Cephalalgia 1992;12:81–4.
   PubMed Web of Science ®Google Scholar
• Hering R, Kuritzky A. Sodium valproate in the treatment of cluster headache: an open clinical trial. Cephalalgia 1989;9:195–8.
   PubMed Web of Science ®Google Scholar
• Shaygannejad V, Janghorbani M, Ghorbani A, Comparison of the effect of topiramate and sodium valproate in migraine prevention: a randomized blinded cross over study. Headache 2006;46:642–8.
   PubMed Web of Science ®Google Scholar